Nextage Therapeutics Ltd (TLV: NXTG)
Israel
· Delayed Price · Currency is ILS · Price in ILA 77.60
-4.10 (-5.02%)
Jan 19, 2025, 3:49 PM IDT
Nextage Therapeutics Market Cap
Nextage Therapeutics has a market cap or net worth of 26.79 million as of January 21, 2025. Its market cap has increased by 179.22% in one year.
Market Cap
26.79M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
77.60
Market Cap Chart
Since August 31, 2020, Nextage Therapeutics's market cap has decreased from 110.42M to 26.79M, a decrease of -75.74%. That is a compound annual growth rate of -27.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2025 | 26.35M | -0.38% |
| Dec 31, 2024 | 26.45M | 168.30% |
| Dec 31, 2023 | 9.86M | -39.56% |
| Dec 29, 2022 | 16.31M | -71.75% |
| Dec 30, 2021 | 57.75M | -26.29% |
| Dec 31, 2020 | 78.35M | -29.05% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 88.56B |
| Danel (Adir Yeoshua) | 2.52B |
| Kamada | 1.50B |
| Bait Bakfar | 1.04B |
| Novolog (Pharm-Up 1966) | 981.60M |
| Ilex Medical | 877.41M |
| BrainsWay | 702.86M |
| SofWave Medical | 596.96M |